All studies
Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence StudyInterventional
An open label, randomized, four-period, four-sequence single dose, crossover trial in healthy volunteers to determine the relative bioavailability of Dimenhydrinate 50 mg (Test) administered with and without water vs. Vomex A 50 mg Lösung zum Einnehmen im Beutel (Reference 1) and Biodramina 50 mg Comprimidos (Reference 2)
At a glance
Status
Ongoing, recruiting
Phase
Human Pharmacology (Phase I)- Bioequivalence Study
Sponsor
CCDRD Cooperative Clinical Drug Research and Development AG, Hermes Pharma GmbH
Enrolment target
14
Start
02 Oct 2023
Who may be eligible?
Age 18 Years to any · Sex: All
Locations (1)
- —Bulgaria
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.